Literature DB >> 8258014

Persistence of Pseudomonas aeruginosa strains in seven cystic fibrosis patients followed over 20 months.

C Godard1, P Plesiat, Y Michel-Briand.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8258014

Source DB:  PubMed          Journal:  Eur J Med        ISSN： 1165-0478


× No keyword cloud information.
  10 in total

1.  Bacteriocin-mediated competition in cystic fibrosis lung infections.

Authors:  Melanie Ghoul; Stuart A West; Helle Krogh Johansen; Søren Molin; Odile B Harrison; Martin C J Maiden; Lars Jelsbak; John B Bruce; Ashleigh S Griffin
Journal:  Proc Biol Sci       Date:  2015-09-07       Impact factor: 5.349

2.  Genome macrorestriction analysis of sequential Pseudomonas aeruginosa isolates from bronchiectasis patients without cystic fibrosis.

Authors:  S W Hla; K P Hui; W C Tan; B Ho
Journal:  J Clin Microbiol       Date:  1996-03       Impact factor: 5.948

Review 3.  Clinical significance of microbial infection and adaptation in cystic fibrosis.

Authors:  Alan R Hauser; Manu Jain; Maskit Bar-Meir; Susanna A McColley
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

4.  Use of pulsed-field gel electrophoresis as an epidemiologic tool during an outbreak of Pseudomonas aeruginosa lung infections in an intensive care unit.

Authors:  D Talon; G Capellier; A Boillot; Y Michel-Briand
Journal:  Intensive Care Med       Date:  1995-12       Impact factor: 17.440

5.  Propagation of TEM- and PSE-type beta-lactamases among amoxicillin-resistant Salmonella spp. isolated in France.

Authors:  C Llanes; V Kirchgesner; P Plesiat
Journal:  Antimicrob Agents Chemother       Date:  1999-10       Impact factor: 5.191

6.  Persistence of a multidrug-resistant Pseudomonas aeruginosa clone in an intensive care burn unit.

Authors:  P R Hsueh; L J Teng; P C Yang; Y C Chen; S W Ho; K T Luh
Journal:  J Clin Microbiol       Date:  1998-05       Impact factor: 5.948

7.  Genotypic analysis of Burkholderia cepacia isolates from 13 French cystic fibrosis centers.

Authors:  C Segonds; E Bingen; G Couetdic; S Mathy; N Brahimi; N Marty; P Plesiat; Y Michel-Briand; G Chabanon
Journal:  J Clin Microbiol       Date:  1997-08       Impact factor: 5.948

8.  A major Pseudomonas aeruginosa clone common to patients and aquatic habitats.

Authors:  U Römling; J Wingender; H Müller; B Tümmler
Journal:  Appl Environ Microbiol       Date:  1994-06       Impact factor: 4.792

Review 9.  Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia.

Authors:  J R Govan; V Deretic
Journal:  Microbiol Rev       Date:  1996-09

10.  In vivo emergence of multidrug-resistant mutants of Pseudomonas aeruginosa overexpressing the active efflux system MexA-MexB-OprM.

Authors:  I Ziha-Zarifi; C Llanes; T Köhler; J C Pechere; P Plesiat
Journal:  Antimicrob Agents Chemother       Date:  1999-02       Impact factor: 5.191
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.